** Analysts at Morgan Stanley say Ansell Ltd's ANN.AX FY24
guidance was "disappointing"
** The medical gloves maker on Tuesday said it planned to
temporarily slow down output in fiscal 2024, hitting core profit
** Guidance for FY24 significantly weaker than anticipated,
increasing uncertainty on its outlook - Morgan Stanley
** Brokerage cuts PT to A$23.28 from A$28.07
** Ansell shares rise as much as 3.6% to A$24.12
** About 539,300 shares change hands versus 30-day average
volume of 424,524 shares
** Ten analysts rate stock "hold" and 2 "sell;" median PT
A$25.00 – Refinitiv data
** Stock down ~18% this year, as of last close
(Reporting by Poonam Behura in Bengaluru)
((Poonam.Behura@thomsonreuters.com;))